# A Research Study to Compare Two Types of Insulin, a New Insulin, Insulin Icodec and an Available Insulin, Insulin Degludec, in People With Type 2 Diabetes Who Have Not Used Insulin Before (ONWARDS 3)

> **NCT04795531** · PHASE3 · COMPLETED · sponsor: **Novo Nordisk A/S** · enrollment: 588 (actual)

## Conditions studied

- Diabetes Mellitus, Type 2

## Interventions

- **DRUG:** Insulin icodec
- **DRUG:** Placebo insulin icodec
- **DRUG:** Insulin degludec
- **DRUG:** Placebo insulin degludec

## Key facts

- **NCT ID:** NCT04795531
- **Lead sponsor:** Novo Nordisk A/S
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-03-24
- **Primary completion:** 2022-06-23
- **Final completion:** 2022-06-23
- **Target enrollment:** 588 (ACTUAL)
- **Last updated:** 2024-12-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04795531

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04795531, "A Research Study to Compare Two Types of Insulin, a New Insulin, Insulin Icodec and an Available Insulin, Insulin Degludec, in People With Type 2 Diabetes Who Have Not Used Insulin Before (ONWARDS 3)". Retrieved via AI Analytics 2026-07-29 from https://api.ai-analytics.org/clinical/NCT04795531. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*